Laurus Labs has reached to an Agreement with Krka, an international generic pharmaceutical company in Novo Mesto, Slovenia to establish a joint venture (JV) company in Hyderabad, India (namely Krka Pharma). In this JV Company, Krka will hold 51% and Laurus 49% shareholding. The registered capital of the newly founded company shall be up to Indian rupees equivalent to 50 million euros.
The joint venture will enable the production of finished products for the new markets, including the Indian market. It is expected that the necessary procedures and documentation for the registration of the new joint venture company will be finalised by the end of March 2024. Laurus and Krka have agreed on a step-by-step development of the joint venture company.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1841.50 |
Dr. Reddys Lab | 1355.15 |
Cipla | 1489.20 |
Lupin | 2181.60 |
Zydus Lifesciences | 959.55 |
View more.. |